Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

hypodermic Pinpoint™ GT Needle

K-Number: K163437 · 2017-06-23

Decision Date2017-06-23
Product CodePVZ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

hypodermic Pinpoint™ GT Needle is a medical device manufactured by C.R. Bard, Inc.. It received FDA 510(k) clearance on 2017-06-23 under approval number K163437. The device is classified under product code PVZ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the hypodermic Pinpoint™ GT Needle?

hypodermic Pinpoint™ GT Needle is a medical device that received FDA 510(k) clearance on 2017-06-23. It is manufactured by C.R. Bard, Inc.. The 510(k) number is K163437.

When was hypodermic Pinpoint™ GT Needle approved by the FDA?

hypodermic Pinpoint™ GT Needle received FDA 510(k) clearance on 2017-06-23, under approval number K163437.

What company makes hypodermic Pinpoint™ GT Needle?

hypodermic Pinpoint™ GT Needle is manufactured by C.R. Bard, Inc..

What is the FDA product code for hypodermic Pinpoint™ GT Needle?

The FDA product code for hypodermic Pinpoint™ GT Needle is PVZ.

Related Clinical Trials

Other Devices by C.R. Bard, Inc.

View all 67 devices →

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.